{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:31:20Z","timestamp":1793043080780,"version":"4.5.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jid.2020.03.945","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T05:10:23Z","timestamp":1587445823000},"page":"931-938.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Research Techniques Made Simple: Randomized\u00a0Controlled Trials for Topical Drugs in\u00a0Dermatology: When\u00a0and How Should We Use a\u00a0Within-Person Design?"],"prefix":"10.1016","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4860-6365","authenticated-orcid":false,"given":"Sophie","family":"Leducq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4715-6144","authenticated-orcid":false,"given":"Agn\u00e8s","family":"Caille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1385-6839","authenticated-orcid":false,"given":"Laurence","family":"Le Cleach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6742-9088","authenticated-orcid":false,"given":"Mahtab","family":"Samimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0798-1182","authenticated-orcid":false,"given":"Elsa","family":"Tavernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3734-810X","authenticated-orcid":false,"given":"Annabel","family":"Maruani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3031-8258","authenticated-orcid":false,"given":"Bruno","family":"Giraudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2020.03.945_bib1","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/jid.2014.527","article-title":"Maintenance therapy of adult vitiligo with 0.1% tacrolimus ointment: a randomized, double blind, placebo\u2013controlled study","volume":"135","author":"Cavali\u00e9","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2020.03.945_bib2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1365-2125.2011.04128.x","article-title":"Convective transport of highly plasma protein bound drugs facilitates direct penetration into deep tissues after topical application","volume":"73","author":"Dancik","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jid.2020.03.945_bib3","first-page":"1","article-title":"Topical minocycline and tetracycline rinses in treatment of recurrent aphthous stomatitis: a randomized cross-over study","volume":"13","author":"Gorsky","year":"2007","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jid.2020.03.945_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40268-013-0004-x","article-title":"Acceptability and efficacy of an emollient containing ceramide-precursor lipids and moisturizing factors for atopic dermatitis in pediatric patients","volume":"13","author":"Hon","year":"2013","journal-title":"Drugs R D"},{"key":"10.1016\/j.jid.2020.03.945_bib5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1186\/s13063-019-3767-8","article-title":"Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial","volume":"20","author":"Leducq","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.jid.2020.03.945_bib6","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1002\/sim.3634","article-title":"The design and analysis of split-mouth studies: what statisticians and clinicians should know","volume":"28","author":"Lesaffre","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.jid.2020.03.945_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta23580","article-title":"A\u00a0behaviour change package to prevent hand dermatitis in nurses working in health care: the SCIN cluster RCT","volume":"23","author":"Madan","year":"2019","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jid.2020.03.945_bib8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/jid.2014.296","article-title":"Comparative effectiveness of topical drugs in dermatologic priority diseases: geometry of randomized trial networks","volume":"135","author":"Maruani","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2020.03.945_bib9","doi-asserted-by":"crossref","first-page":"j2835","DOI":"10.1136\/bmj.j2835","article-title":"CONSORT 2010 statement: extension checklist for reporting within person randomised trials","volume":"357","author":"Pandis","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jid.2020.03.945_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12895-016-0051-4","article-title":"Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a phase 2b randomized clinical trial","volume":"16","author":"Papp","year":"2016","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.jid.2020.03.945_bib11","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jamadermatol.2017.1130","article-title":"Medicare Part D payments for topical steroids: rising costs and potential savings","volume":"153","author":"Song","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2020.03.945_bib12","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/bjd.16667","article-title":"A\u00a0smartphone application supporting patients with psoriasis improves adherence to topical treatment: a randomized controlled trial","volume":"179","author":"Svendsen","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2020.03.945_bib13","first-page":"CD003263","article-title":"Interventions for vitiligo","author":"Whitton","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jid.2020.03.945_bib14","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.jid.2016.05.104","article-title":"How clinically relevant are treatment comparisons of topical calcineurin inhibitor trials for atopic eczema?","volume":"136","author":"Wilkes","year":"2016","journal-title":"J\u00a0Invest Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X20312598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X20312598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:16:45Z","timestamp":1758302205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X20312598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0022202X20312598"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2020.03.945","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research Techniques Made Simple: Randomized\u00a0Controlled Trials for Topical Drugs in\u00a0Dermatology: When\u00a0and How Should We Use a\u00a0Within-Person Design?","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2020.03.945","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Society for Investigative Dermatology","name":"copyright","label":"Copyright"}]}}